Clinical Trials Browser

Hypersensitivity × BNT162 Vaccine × Myeloid × Clear all

NCT04761822 2025-08-12

SARS

Phase 2 Completed

746 enrolled 28 charts

COVID-19, Hypersensitivity, Mastocytosis, Severe Acute Respiratory Syndrome